RAPT Therapeutics, Inc. — Director's Dealing 2021

Apr 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-03-31

Reporting Person: Svennilson Peter (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-31	Stock Option (right to buy)	$22.20	A	2229	Acquired	2031-03-30	Common Stock (2229)	Direct

Footnotes

F1: This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $35,000.

F2: The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2021 with the first installment vesting on March 31, 2021, provided that the reporting person is in service as a director on each such vesting date.